134 related articles for article (PubMed ID: 19123142)
21. Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.5% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial.
Baiza-Durán L; Olvera-Montaño O; Mercado-Sesma AR; Oregon-Miranda AA; Lizárraga-Corona A; Ochoa-Tabares JC; Pérez-Balbuena AL; Montoya-Sánchez IM; Saucedo-Rodríguez LR; Mora-González A; Gómez-Bastar PA; Villanueva-Najera MA; Sandoval-Delgadillo LI; González-Lomelí M; Páez-Garza JH; Orozco-Carroll M; Casillas-Magallanes M
J Ocul Pharmacol Ther; 2018 Apr; 34(3):250-255. PubMed ID: 29624493
[TBL] [Abstract][Full Text] [Related]
22. Twice-a-day versus four-times-a-day ofloxacin treatment of external ocular infection.
Friedlaender MH
CLAO J; 1998 Jan; 24(1):48-51. PubMed ID: 9474454
[TBL] [Abstract][Full Text] [Related]
23. Post-marketing surveillance of levofloxacin 0.5% ophthalmic solution for external ocular infections.
Kanda Y; Kayama T; Okamoto S; Hashimoto M; Ishida C; Yanai T; Fukumoto M; Kunihiro E
Drugs R D; 2012 Dec; 12(4):177-85. PubMed ID: 23075336
[TBL] [Abstract][Full Text] [Related]
24. [Clinical research of isatis root eyedrops on the acute bacterial conjunctivitis].
Qi CX; Wu XM; Wang XL
Zhong Yao Cai; 2007 Jan; 30(1):120-2. PubMed ID: 17539316
[TBL] [Abstract][Full Text] [Related]
25. Treatment of acute bacterial conjunctivitis with topical lomefloxacin 0.3% compared to topical ofloxacin 0.3%.
Tabbara KF; El-Sheikh HF; Islam SM; Hammouda E
Eur J Ophthalmol; 1999; 9(4):269-75. PubMed ID: 10651190
[TBL] [Abstract][Full Text] [Related]
26. 3-day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: multicentre, randomised and controlled trial in adults and children.
Cochereau I; Meddeb-Ouertani A; Khairallah M; Amraoui A; Zaghloul K; Pop M; Delval L; Pouliquen P; Tandon R; Garg P; Goldschmidt P; Bourcier T
Br J Ophthalmol; 2007 Apr; 91(4):465-9. PubMed ID: 17050578
[TBL] [Abstract][Full Text] [Related]
27. Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study.
Gallenga PE; Lobefalo L; Colangelo L; Della Loggia G; Orzalesi N; Velati P; Bujtar E; Ponte F; Damiani S; Bucci MG; Bonini S; Curatola MR; Palma LA; Bonomi L; Tomazzoli Gerosa L; Pagliarusco A; Milan E; Jauch A
Ophthalmologica; 1999; 213(4):250-7. PubMed ID: 10420109
[TBL] [Abstract][Full Text] [Related]
28. Tear concentration and safety of levofloxacin ophthalmic solution 1.5% compared with ofloxacin ophthalmic solution 0.3% after topical administration in healthy adult volunteers.
Walters T; Rinehart M; Krebs W; Holdbrook M
Cornea; 2010 Mar; 29(3):263-8. PubMed ID: 20098307
[TBL] [Abstract][Full Text] [Related]
29. A prospective study determining the efficacy of topical 0.5% levofloxacin on bacterial flora of patients with chronic blepharoconjunctivitis.
Yactayo-Miranda Y; Ta CN; He L; Kreutzer TC; Nentwich MM; Kampik A; Mino de Kaspar H
Graefes Arch Clin Exp Ophthalmol; 2009 Jul; 247(7):993-8. PubMed ID: 19205719
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of azithromycin 1.5% eye drops in paediatric population with purulent bacterial conjunctivitis.
Bremond-Gignac D; Nezzar H; Bianchi PE; Messaoud R; Lazreg S; Voinea L; Speeg-Schatz C; Hartani D; Kaercher T; Kocyla-Karczmarewicz B; Murta J; Delval L; Renault D; Chiambaretta F;
Br J Ophthalmol; 2014 Jun; 98(6):739-45. PubMed ID: 24526744
[TBL] [Abstract][Full Text] [Related]
31. Besifloxacin: a topical fluoroquinolone for the treatment of bacterial conjunctivitis.
Chang MH; Fung HB
Clin Ther; 2010 Mar; 32(3):454-71. PubMed ID: 20399984
[TBL] [Abstract][Full Text] [Related]
32. Prospective randomized comparison of 1-day versus 3-day application of topical levofloxacin in eliminating conjunctival flora.
Ta CN; Sinnar S; He L; Myung D; Miño De Kaspar H
Eur J Ophthalmol; 2007; 17(5):689-95. PubMed ID: 17932841
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of clinical efficacy and safety of tobramycin/dexamethasone ophthalmic suspension 0.3%/0.05% compared to azithromycin ophthalmic solution 1% in the treatment of moderate to severe acute blepharitis/blepharoconjunctivitis.
Torkildsen GL; Cockrum P; Meier E; Hammonds WM; Silverstein B; Silverstein S
Curr Med Res Opin; 2011 Jan; 27(1):171-8. PubMed ID: 21138337
[TBL] [Abstract][Full Text] [Related]
34. [Efficacy assessment of azithromycin 1.5% eye drops versus tobramycin 0.3% on clinical signs of purulent bacterial conjunctivitis].
Robert PY; Bourcier T; Meddeb-Ouertani A; Khairallah M; Zaghloul K; Amraoui A; Bhagat Y; Pop M; Cochereau I
J Fr Ophtalmol; 2010 Apr; 33(4):241-8. PubMed ID: 20223555
[TBL] [Abstract][Full Text] [Related]
35. Besifloxacin Ophthalmic Suspension 0.6% Compared with Gatifloxacin Ophthalmic Solution 0.3% for the Treatment of Bacterial Conjunctivitis in Neonates.
Sanfilippo CM; Allaire CM; DeCory HH
Drugs R D; 2017 Mar; 17(1):167-175. PubMed ID: 28078599
[TBL] [Abstract][Full Text] [Related]
36. The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.
Benitez-Del-Castillo J; Verboven Y; Stroman D; Kodjikian L
Clin Drug Investig; 2011; 31(8):543-557. PubMed ID: 21604820
[TBL] [Abstract][Full Text] [Related]
37. Clinical and Antibacterial Efficacy and Safety of Besifloxacin Ophthalmic Suspension Compared With Moxifloxacin Ophthalmic Solution.
Garg P; Mathur U; Sony P; Tandon R; Morris TW; Comstock TL
Asia Pac J Ophthalmol (Phila); 2015; 4(3):140-5. PubMed ID: 26065499
[TBL] [Abstract][Full Text] [Related]
38. The safety of besifloxacin ophthalmic suspension 0.6 % used three times daily for 7 days in the treatment of bacterial conjunctivitis.
Malhotra R; Ackerman S; Gearinger LS; Morris TW; Allaire C
Drugs R D; 2013 Dec; 13(4):243-52. PubMed ID: 24142473
[TBL] [Abstract][Full Text] [Related]
39. Levofloxacin 0.5% ophthalmic solution: a review of its use in the treatment of external ocular infections and in intraocular surgery.
Keating GM
Drugs; 2009 Jun; 69(9):1267-86. PubMed ID: 19537841
[TBL] [Abstract][Full Text] [Related]
40. [Use of the antibacterial agent levofloxacin for acute upper respiratory tract infection accompanied by fever (> or = 38 degrees C)].
Yamaguchi H; Uchino K; Yokoyama H; Matsumoto T; Odagiri S
Jpn J Antibiot; 2003 Dec; 56(6):719-36. PubMed ID: 15007881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
